The present study aims to evaluate the performance of CEA, CYFRA21-1 and CA125 for the early detection of CRC in an asymptomatic cohort by profiling tumour marker levels in four annual longitudinal serum samples collected from women who subsequently developed CRC, benign neoplasms of the colorectum or remained cancer free. This evidence concerns the gene MUC16 and benign neoplasm.